In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide

International Journal of Pharmaceutics

Volumn 428, Issue 1-2, 2012, Pages 118-120

  Elkordy, Amal Ali ^a   Jatto, Ayobami ^a   Essa, Ebtessam ^b,c  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

^c Tanta University   (Egypt)

Author keywords

Controlled crystallization; Cremophor RH40; Glibenclamide; Solutol HS 15

Indexed keywords

CREMOPHOR; GLIBENCLAMIDE; GLYCOPROTEIN P; SOLUTOL HS 15;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISPERSION; DRUG ABSORPTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSPORT; INTESTINE ABSORPTION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

BIOLOGICAL TRANSPORT; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; EXCIPIENTS; GLYBURIDE; INTESTINAL ABSORPTION; P-GLYCOPROTEINS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SOLUBILITY; STEARIC ACIDS; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 84859420877     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.02.046     Document Type: Article

References (14)

1. Benoit, J.P., Lanprecht, L., 2004. Use of p-glycoprotein inhibitor surfactant at the surface of a colloidal carrier. Patent W02004071498.
2. J.S. Coon, W. Knudson, K. Clodfelter, B. Lu, and R.S. Weinstein Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance Cancer Res. 51 1991 897 902
3. M.T. Esclusa-Díaz, J.J. Torres-Labandeira, M. Kata, and J.L. Vila-Jato Inclusion complexation of glibenclamide with 2-hydroxypropyl-β- cyclodextrin in solution and in solid state Eur. J. Pharm. Sci. 16 1994 291 296 (Pubitemid 24208431)
4. M.A. Hassan, M. Sheikh Salem, E. Sallam, and M.K. Al-Hindawi Preparation and characterization of a new polymorphic form and a solvate of glibenclamide Acta Pharm. Hung. 672 1997 81 88 (Pubitemid 27292213)
5. K.A. Khan The concept of dissolution efficiency J. Pharm. Pharmacol. 28 1975 48 49
6. S.T. Kim, J.H. Kwon, J.J. Lee, and C.W. Kim Microcrystallization of indomethacin using a pH-shift method Int. J. Pharm. 263 2003 141 150 (Pubitemid 37087941)
7. Peltier Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules Pharm. Res. 33 2006 1243 1249
8. N. Rasenack, and B.W. Muller Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs Pharm. Res. 19 2002 1894 1900 (Pubitemid 36016039)
9. N. Rasenack, H. Steckel, and B.W. Müller Preparation of microcrystals by in situ micronization Powder Technol. 143-144 2004 291 296 (Pubitemid 39091949)
10. B.D. Rege, J.P. Kao, and J.E. Polli Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur. J. Pharm. Sci. 16 2002 237 246
11. P. Srirangam, and S.J. Vidya Modulation of the P-glycoproein-mediated intestinal secretion of Glibenclamide: in vitro and in vivo assessments J. Young Pharm. 2 2010 379 383
12. M. Valleri, P. Mura, F. Maestrelli, M. Cirri, and R. Ballerini Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique Drug Dev. Ind. Pharm. 305 2004 525 534 (Pubitemid 38821864)
13. J. Varshosaz, R. Talari, A. Mostafavi, and A. Nokhodchi Dissolution enhancement of gliclazide using in situ micronization by solvent change method Powder Technol. 187 2008 222 230
14. H. Wei, R. Lacan, and M. Cirri Biorelevant dissolution media as a predictive tool for glyburide a class II drug Eur. J. Pharm. Sci. 19 2006 45 62